Novel eicosanoid activators of PPARγ formed by raw 264.7 macrophage cultures

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 343-349

  Hammarstrom, Sven ^a   Trinks, Cecilia ^a   Wigren, Jane ^a   Surapureddi, Sailesh ^a   Soderstrom, Matts ^a   Glass, Christopher K ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN D2; 15 DEOXY DELTA 12,14 PROSTAGLANDIN D2; DELTA 12 PROSTAGLANDIN D2; GAMMA INTERFERON; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDIN D2 DERIVATIVE; UNCLASSIFIED DRUG; CELL RECEPTOR; ICOSANOID; TRANSCRIPTION FACTOR;

ANIMAL CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; EXTRACTION; INCUBATION TIME; LIQUID CHROMATOGRAPHY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; ARTICLE; CELL LINE; DRUG EFFECT; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MACROPHAGE ACTIVATION; METABOLISM; PERITONEUM MACROPHAGE; PHYSIOLOGY; PLASMID;

ANIMALIA;

ANIMALS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EICOSANOIDS; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; PLASMIDS; PROSTAGLANDIN D2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0038784209     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_53     Document Type: Conference Paper

References (13)

1. Fitzpatrick, F.A., and Wynalda, M.A. (1983) J. Biol. Chem. 258, 11713-8
2. Kikawa, Y., Narumiya, S., Fukushima, M., Wakatsuka, H., and Hayaishi, O. (1984) Proc. Natl. Acad. Sci. USA 81, 1317-21
3. Kato, T., Fukushima, M., Kurozumi, S., and Noyori, R. (1986) Cancer Res 46, 3538-42
4. Narumiya, S., and Fukushima, M. (1986) J. Pharmacol. Exp. Ther. 239, 500-5
5. Narumiya, S., Ohno, K., Fujiwara, M. and Fukushima, M. (1986) J. Pharmacol. Exp. Ther. 239, 506-11
6. Narumiya, S., Ohno, K., Fukushima, M. and Fujiwara, M. (1987) J. Pharmacol. Exp. Ther. 242, 306-11
7. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M. (1995) Cell 83, 803-12
8. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D.C. and Lehmann, J. M. (1995) Cell 83, 813-9
9. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., and Glass, C. K. (1998) Nature 391, 79-82
10. Powell, W. S. (1982) Methods Enzymol. 86, 467-77
11. Bundy, G. L., Morton, D. R., Peterson, D. C., Nishizawa, E. E., and Miller, W. L., (1983) J. Med. Chem. 26, 790-9
12. DiRenzo, J., Söderström, M., Kurokawa, R., Ogliastro, M. H., Ricote, M., Ingrey, S., Hörlein, A., Rosenfeld, M. G., and Glass, C. K. (1997) Mol. Cell. Biol. 17, 2166-76
13. Krey, G., Braissant, O., L 'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., and Wahli, W. (1997) Mol. Endrocrinology. 11, 779-91